| AMCZX | FSMAX | AMCZX / FSMAX | |
| Total Expense Ratio | 0.79 | 0.04 | 2,257% |
| Annual Report Gross Expense Ratio | 0.92 | 0.04 | 2,629% |
| Fund Existence | 11 years | 15 years | - |
| Gain YTD | 4.169 | 13.370 | 31% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 500000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 294M | 40.1B | 1% |
| Annual Yield % from dividends | 0.00 | 0.50 | - |
| Returns for 1 year | 8.16 | 20.57 | 40% |
| Returns for 3 years | 49.46 | 55.83 | 89% |
| Returns for 5 years | -14.65 | 33.18 | -44% |
| Returns for 10 years | 90.04 | 133.82 | 67% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ESGV | 132.02 | 0.89 | +0.68% |
| Vanguard ESG US Stock ETF | |||
| SPMV | 50.75 | N/A | N/A |
| Invesco S&P 500 Minimum Variance ETF | |||
| BNDP | 73.11 | -0.17 | -0.23% |
| Vanguard Core-Plus Bond Index ETF | |||
| NIM | 9.16 | -0.03 | -0.33% |
| Nuveen Select Maturities Municipal Fund | |||
| HQL | 19.10 | -0.34 | -1.75% |
| abrdn Life Sciences Investors | |||